Literature DB >> 11852880

NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite.

Akiko Shiotani1, Yoshio Yamaoka, Hala M T El-Zimaity, M Ali Saeed, Waqar A Qureshi, David Y Graham.   

Abstract

NSAID use and Helicobacter pylori both cause damage to the gastric mucosa and can cause peptic ulcers. Our aim was to test the relationship between gastric mucosal polymorphonuclear leukocyte (PMN) infiltration and the severity of NSAID-induced gastric injury. H. pylori density, mucosal interleukin-8 (IL-8), and nitrite levels were assessed after receiving placebo and again after receiving 1000 mg of naproxen daily for three days. Histology was graded using a visual analog scale (0-5). IL-8 levels were assayed by ELISA and nitrite levels by Griess reaction. Eleven healthy volunteers with H. pylori infection entered. All had normal-appearing gastric mucosa after placebo. Postnaproxen gastric damage included three with none, one with mild, three with moderate, two with severe, and three were very severe mucosal injury (including one with an ulcer >5 mm). There was an inverse correlation between endoscopic score and the pH of the gastric juice post-therapy (R = -0.77, P = 0.004). There was no significant change in histologic or biochemical parameters from pretreatment levels. And none of the parameters (eg, PMN density) predicted endoscopic outcome. In conclusion, there was no relation between mucosal PMN density and endoscopic mucosa injury. PMN infiltration, while not predictive, may be a surrogate for an H. pylori infection-related increased risk of NSAID ulcers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852880     DOI: 10.1023/a:1013251100950

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

2.  Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Authors:  C Aalykke; J M Lauritsen; J Hallas; S Reinholdt; K Krogfelt; K Lauritsen
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

3.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

Authors:  N D Yeomans; Z Tulassay; L Juhász; I Rácz; J M Howard; C J van Rensburg; A J Swannell; C J Hawkey
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

4.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Authors:  C J Hawkey; J A Karrasch; L Szczepañski; D G Walker; A Barkun; A J Swannell; N D Yeomans
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

5.  Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.

Authors:  J L Wallace; W McKnight; P Del Soldato; A R Baydoun; G Cirino
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.

Authors:  D J Cullen; G M Hawkey; D C Greenwood; H Humphreys; V Shepherd; R F Logan; C J Hawkey
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

7.  A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats.

Authors:  S N Elliott; W McKnight; G Cirino; J L Wallace
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

8.  Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.

Authors:  N M Agrawal; S Roth; D Y Graham; R H White; B Germain; J A Brown; S C Stromatt
Journal:  Ann Intern Med       Date:  1991-08-01       Impact factor: 25.391

Review 9.  Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined.

Authors:  J L Wallace
Journal:  Scand J Gastroenterol Suppl       Date:  1992

10.  Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.

Authors:  L Laine; F Cominelli; R Sloane; V Casini-Raggi; M Marin-Sorensen; W M Weinstein
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171

View more
  6 in total

Review 1.  NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.

Authors:  Jørgen Naesdal; Kurt Brown
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

Authors:  Akiko Shiotani; Takashi Sakakibara; Yoshiyuki Yamanaka; Ryuji Nishi; Hiroshi Imamura; Minoru Fujita; Ken-ichi Tarumi; Tomoari Kamada; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-05-16       Impact factor: 7.527

3.  Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin.

Authors:  Akiko Shiotani; Takashi Sakakibara; Yoshiyuki Yamanaka; Hiroshi Imamura; Ken-Ichi Tarumi; Noriaki Manabe; Tomoari Kamada; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

Review 4.  Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

Authors:  Marco Lazzaroni; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

5.  Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Masahiko Nakasono; Yasuteru Fujino; Yasuhiro Mitsui; Yoshihumi Takaoka; Tetsuo Kimura; Koichi Okamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in korean patients with chronic gastritis.

Authors:  Hak Yang Kim; Ki-Baik Hahm; Myung-Gyu Choi; Jong-Sun Rew; Sang-Young Seol; Hoon-Jai Chun; Oh-Young Lee; Weon-Seon Hong
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.